Home > PS Ratio > AARTI PHARMALABS

AARTI PHARMALABS
PS (Price/Sales) Ratio

The Current P/S Ratio of AARTI PHARMALABS is 2.87.

Share Price ₹586.7May 15,2024
Market Cap ₹5,315.5 Cr
Sales-TTM₹1,852.6 CrTTM-Consolidated Results
Price/Sales2.87xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for AARTI PHARMALABS
Please provide your vote to see the results
AARTI PHARMALABS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of AARTI PHARMALABS

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of AARTI PHARMALABS is calculated as :

Current Market Cap [ ₹5,315.5 Cr] as on May 15,2024

(/) Sales [ ₹1,852.6 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 2.87x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for AARTI PHARMALABS , the investors are currently willing to pay '2.87 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of AARTI PHARMALABS !

The chart below summarizes the trend in P/S Ratio of AARTI PHARMALABS over the last five years.

Historical PS (Price/Sales) ratio chart of AARTI PHARMALABS


PS Ratio Performance Analysis for AARTI PHARMALABS

- AARTI PHARMALABS 's latest p/e ratio is 2.87x.

- AARTI PHARMALABS 's p/e ratio for fiscal years ending Mar2023 to Mar2021 averaged 0.43x.

- AARTI PHARMALABS 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.

- Looking back at the last 3 fiscal years, AARTI PHARMALABS 's p/e ratio peaked in Mar2023 at 1.28x.

- AARTI PHARMALABS 's p/e ratio hit its five-year low in Mar2022 of 0x.


How does AARTI PHARMALABS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
AARTI PHARMALABS 1,852.62.875,315.5
SUN PHARMACEUTICAL INDUSTRIES LTD47,444.67.72366,354.0
CIPLA LTD25,774.14.40113,516.0
DR REDDYS LABORATORIES LTD28,011.13.5097,961.5
ZYDUS LIFESCIENCES LTD19,024.25.28100,367.0
DIVIS LABORATORIES LTD7,492.813.79103,352.0
MANKIND PHARMA LTD9,946.38.8287,765.1
TORRENT PHARMACEUTICALS LTD10,474.08.5789,710.0
LUPIN LTD20,010.83.7374,702.0
AUROBINDO PHARMA LTD27,894.72.4367,881.0
ABBOTT INDIA LTD5,848.99.6056,170.8

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs AARTI PHARMALABS 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.43x
Max industry PS 13.79x
Median industry PS 5.28x
Average industry PS 6.43x



You may also like the below Video Courses